ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
40 announcements
Vijaya Diagnostic Centre held its 24th Annual General Meeting on September 24, 2026. Shareholders transacted ordinary and special business, including declaring a final dividend.
Vijaya Diagnostic Centre is acquiring 100% of Arya Wellness Centre in Guwahati. The company published an investor presentation detailing the acquisition's strategic rationale and financial highlights.
Vijaya Diagnostic Centre acquires the diagnostic business undertaking of Arya Wellness Centre for ₹46.20 Crore on a slump sale basis to expand its North-East India presence.
Vijaya Diagnostic Centre Ltd acquired the integrated diagnostic business of Arya Wellness Centre for ₹46.20 Crore. This slump sale expands its presence into the North-East.
Vijaya Diagnostic Centre Limited has appointed Dr. Venkata Naresh Yallapragada as the new Chief Information Officer (CIO). This leadership change is effective from September 2, 2026.
Vijaya Diagnostic Centre Ltd has sent web-link letters to shareholders whose email addresses are not registered, enabling access to the Annual Report for FY 2025-26.
Vijaya Diagnostic Centre Limited filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26, fulfilling mandatory SEBI regulatory reporting requirements.
Vijaya Diagnostic Centre Ltd submitted its Annual Report for FY 2025-26, which includes the notice for the 24th Annual General Meeting scheduled for September 24, 2026.
Dr. Manjula Anagani has ceased to be an Independent Director of Vijaya Diagnostic Centre Ltd effective August 21, 2026, upon the completion of her tenure.
Vijaya Diagnostic Centre will hold its 24th Annual General Meeting on September 24, 2026. The company fixed September 16, 2026, as the record date for dividend entitlement.
Vijaya Diagnostic Centre distributed Rs. 0.52 Crore in net sale proceeds from fractional entitlements to shareholders. This follows its NCLT-approved amalgamation with Medinova Diagnostic Services.
Vijaya Diagnostic reports strong Q1 FY27 results with 22.8% YoY revenue growth, driven by volume expansion and new hub commissions in Bengaluru and Hyderabad.
Vijaya Diagnostic Centre reported Q1 FY27 results with 22.8% YoY revenue growth. The company also commissioned four new spokes in Hyderabad, Andhra Pradesh, and Pune.
Vijaya Diagnostic Centre Ltd reported revenue from operations of ₹231 Cr (+22.8% YoY) and net profit of ₹53.1 Cr (+37.6% YoY) for Q1 FY27.
HDFC Mutual Fund acquired shares of Vijaya Diagnostic Centre, taking its total holding to 5.003% of the paid-up equity share capital.
Vijaya Diagnostic Centre scheduled a board meeting for August 6, 2026. The board will consider un-audited financial results for the quarter ended June 30, 2026.
The company filed its quarterly shareholding pattern under SEBI Regulation 31(1)(b) for the period ending June 30, 2026, disclosing promoter and public shareholdings.
Vijaya Diagnostic Centre allotted 100,987 equity shares under the VDCL Employee Stock Option Plan 2018. This allotment expands the company's issued share capital.
Vijaya Diagnostic Centre Ltd issued a Postal Ballot notice seeking shareholder approval for the appointment of two Independent Directors. E-voting runs from July 21 to August 20, 2026.
Vijaya Diagnostic Centre granted 90,000 ESOPs at Rs. 956 per share, totaling Rs. 8.60 Crore. Options vest over three years for support function employees.
Vijaya Diagnostic Centre appointed Mr. Narasimha Raju K.A. as Chief Financial Officer effective July 09, 2026. He brings over 20 years of experience, previously serving at Yashoda Hospitals.
abrdn Asia Limited sold 133,199 shares (≈0.13% of capital) of Vijaya Diagnostic Centre Ltd in an open‑market transaction. Its stake fell from 3.37% to 3.24%.
Mr. Ankit Shah has resigned as Chief Financial Officer of Vijaya Diagnostic Centre effective July 24, 2026. The company is now identifying a suitable successor.
Vijaya Diagnostic Centre appointed Ms. Naga Vasudha Tadepalli as Company Secretary and Compliance Officer effective June 01, 2026. She brings sixteen years of legal and regulatory experience.
Vijaya Diagnostic Centre appointed Mr. Satyanaryana Murthy Chavali and Mr. Dipinder Singh Sekhon as Independent Directors. Their terms are five and two years, strengthening board governance.
Independent Directors Shekhar Prasad Singh and Satyanaryana Murthy Chavali ceased roles following tenure completion. Their departures were effective May 25, 2026, as per regulatory filings.
Vijaya Diagnostic reported a landmark FY26 with revenues crossing ₹800cr and Q4 revenue growth of 26.6%. The company is focusing on network expansion and high-end diagnostics like Genomics.
Vijaya Diagnostic Centre shareholders approved the appointment of two Independent Directors via postal ballot. The resolutions passed with requisite majority on May 09, 2026.
Vijaya Diagnostic Centre recommended a final dividend of ₹2 per equity share for FY26. The board will announce the record date and meeting schedule later.
Vijaya Diagnostic reported record FY26 revenue crossing ₹8,000 Mn with 41.4% EBITDA margins. Strategy focuses on deepening presence in South India and scaling West Bengal/Pune hubs.